{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:37:26Z","timestamp":1772746646355,"version":"3.50.1"},"reference-count":9,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.3109\/10428194.2014.893302","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T05:53:50Z","timestamp":1397282030000},"page":"2813-2816","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Deleterious effects of non-branded versions of imatinib used for the treatment of patients with chronic myeloid leukemia in chronic phase: a case series on an escalating issue impacting patient safety"],"prefix":"10.1080","volume":"55","author":[{"given":"Domingo","family":"Saavedra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Vizcarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"key":"CIT0001","volume-title":"Glivec (imatinib mesylate) [prescribing information]","year":"2008"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1182\/blood.V114.22.1126.1126","volume":"114","author":"Deininger M","year":"2009","journal-title":"Blood"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.29"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1159\/000319150"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-2-9342"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0431-1"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-3-7112"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0779"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.111"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2014.893302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T17:43:24Z","timestamp":1597686204000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2014.893302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":9,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,6,27]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3109\/10428194.2014.893302"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2014.893302","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}